About the Company:
Ovelle is revolutionizing fertility treatment through human in vitro oogenesis—producing eggs from somatic cells. We have developed technology to create the cell types of the ovary from human induced pluripotent stem cells (iPSCs) by manipulating expression of transcription factors and RNA-binding proteins. Notably, we are the first company to produce meiotic oocyte-like cells from human iPSCs. This is an important step towards in vitro oogenesis because activating meiosis has been a key challenge in the field. We are incorporating these meiotic oocyte-like cells into ovarian organoids to create synthetic ovaries capable of producing eggs. By innovating egg production, we aim to make fertility treatments more accessible and affordable. If we are successful, it will mark a paradigm shift in treatments for infertility, and offer a new path to parenthood for millions of people around the world. Come help us build the exciting future we all want to live in.
Ovelle is a research-first startup where scientists work together on only one deep and important problem: IVG. We operate like a fast, efficient academic lab without constraints. We’re committed to sharing our work with the scientific community and welcome collaborations with academic researchers.
We recently closed an oversubscribed funding round led by a top-tier VC firm, giving us 3–4 years of runway at our current pace.
We encourage everyone to apply, as we value individuals who bring unique perspectives to our company. We welcome talented researchers; specific expertise in reproductive biology is not required.
Our benefits:
- 12.5 paid holidays
- PTO is three weeks annually, accruing at approximately 1.25 days per month
- Medical, Dental, and Vision
- Matching 401(k) plan
- Up to 12 weeks paid leave for new parents who are primary caregivers
- Tuition reimbursement for work-related continuing education
Interested?
Send us your résumé or CV, LinkedIn profile, and anything else you would like us to know.
Apply for this role